Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
Cervical dystonia (CD) is a neurological movement disorder characterized by sustained involuntary muscle contractions. First-line therapy for CD is intramuscular injections of botulinum neurotoxin (e.g., abobotulinumtoxinA) into the affected muscles. The objective of this systematic literature revie...
Main Authors: | Alfonso Fasano, Vijayashankar Paramanandam, Mandar Jog |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/8/470 |
Similar Items
-
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
by: Jörg Wissel, et al.
Published: (2020-02-01) -
Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
by: Mohammad Sajjad Rahnama'i, et al.
Published: (2024-01-01) -
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
by: Muthukumar M, et al.
Published: (2017-04-01) -
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
by: Mark F. Lew, et al.
Published: (2021-01-01) -
Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral Palsy
by: Joyce Oleszek, et al.
Published: (2021-10-01)